university
ImmunoCellular Therapeutics, Ltd. (IMUC.OB) Announces Research Agreement with George Mason University
Read the full article: http://blog.qualitystocks.net/?p=10716
ImmunoCellular Therapeutics has signed a research agreement with George Mason University for the development of a blood test designed to detect small cell lung cancer and pancreatic cancer using ImmunoCellular’s monoclonal antibody technology.
Vested Interest:
The author does not own shares of IMUC- Login or register to post comments
- Read more
- Email this page
Related Articles
- ImmunoCellular Therapeutics, Ltd. (IMUC.OB) Announces Research Agreement with George Mason University
- GenVec, Inc.’s (GNVC) TNFerade™ Gets FDA Fast Track Designation for Pancreatic Cancer Treatment
- Northfield Laboratories Inc.’s (NFLD) Application for PolyHeme Accepted for Filing and Granted Priority Review
- Lpath Inc. (LPTN.OB) Secures Strategic $23M Alliance to Launch Cancer Treatment Trials
- EXACT Sciences Corporation (EXAS) Announces Published Study Results for the Company’s Colorectal Cancer Detection Technology